Skip to main content
Premium Trial:

Request an Annual Quote

Orchid to Implement One-for-five Reverse Stock Split by End of Month

NEW YORK, March 25 (GenomeWeb News) - Orchid BioSciences will implement a one-for-five reverse stock split, effective March 30, the company said today.

 

Each five shares of Orchid's common stock will be converted into one share, resulting in approximately 22.1 million shares of common stock. Orchid's board of directors recently authorized the reverse split, which was approved by stockholders last month.

 

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.